Antenatal prevention of the neonatal respiratory distress syndrome: benefits and potential risks for the mother and the infant.
D000551:Ambroxol / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D005500:Follow-Up Studies; D005865:Gestational Age; D005938:Glucocorticoids / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects / Q000196:embryology; D008297:Male; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D012306:Risk; D013963:Thyroid Hormones / Q000009:adverse effects / Q000627:therapeutic use
D005938:Glucocorticoids; D013963:Thyroid Hormones; D000551:Ambroxol; D000628:Aminophylline